Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 34 | Neville Patrick SeanDirector | Open-market sale · 10b5-1 plan | SELL | $450K 5,000 sh |
| Dec 16, 2025 traded Dec 12, 2025 |
| 34 | Alclear Investments, LLCDirector, 10% Owner, See Remarks | Open-market sale · 10b5-1 plan | SELL | $11.48M 283.3K sh | Dec 16, 2025 traded Dec 12, 2025 |
| 34 | Desai UjjavalDirector, Chief Executive Officer | Open-market purchase | BUY | $16K 1,162 sh | Dec 16, 2025 traded Dec 12, 2025 |
| 34 | Ellspermann Susan JDirector | Open-market purchase | BUY | $1,000 24 sh | Dec 16, 2025 traded Dec 15, 2025 |
| 33 | Kreps Edward JayDirector, CHIEF EXECUTIVE OFFICER | Open-market sale · 10b5-1 plan | SELL | $7.00M 232.5K sh | Dec 16, 2025 traded Dec 15, 2025 |
| 33 | Fox-Geen JeremyChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $2.14M 23.8K sh | Dec 16, 2025 traded Dec 12, 2025 |
| 33 | Manuel Wayne OSenior Vice President | Open-market sale | SELL | $69K 1,785 sh | Dec 16, 2025 traded Dec 16, 2025 |
| 32 | Beck PeterDirector, CEO | Open-market sale · 10b5-1 plan | SELL | $515K 8,005 sh | Dec 16, 2025 traded Dec 15, 2025 |
| 31 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale | SELL | $1.08M 4,692 sh | Dec 16, 2025 traded Dec 12, 2025 |
| 31 | Alclear Investments, LLCDirector, 10% Owner, See Remarks | Open-market sale · 10b5-1 plan | SELL | $8.86M 214.5K sh | Dec 16, 2025 traded Dec 12, 2025 |
| 30 | Allaire JeremyDirector, Chairman and CEO | Open-market sale · 10b5-1 plan | SELL | $635K 7,055 sh | Dec 16, 2025 traded Dec 12, 2025 |
| 30 | Desai UjjavalDirector, Chief Executive Officer | Open-market purchase | BUY | $13K 1,000 sh | Dec 16, 2025 traded Dec 16, 2025 |
| 30 | Pfeiffenberger BrentDirector, President and CEO | Open-market purchase | BUY | $30K 52.0K sh | Dec 16, 2025 traded Dec 12, 2025 |
| 30 | Desai UjjavalDirector, Chief Executive Officer | Open-market purchase | BUY | $14K 1,000 sh | Dec 16, 2025 traded Dec 15, 2025 |
| 30 | Seger Andrew MDirector | Open-market purchase | BUY | $1,100 27 sh | Dec 16, 2025 traded Dec 15, 2025 |
| 56 | Fortunato DavidDirector, CEO and President | Open-market sale | SELL | $10.71M 765.2K sh | Dec 15, 2025 traded Dec 11, 2025 |
| 53 | Fortunato DavidDirector, CEO and President | Open-market sale | SELL | $1.34M 95.4K sh | Dec 15, 2025 traded Dec 11, 2025 |
| 53 | Wetterwald JulienChief Technology Officer | Open-market sale | SELL | $1.68M 120.0K sh | Dec 15, 2025 traded Dec 11, 2025 |
| 53 | Imberman AlanCFO and Treasurer | Open-market sale | SELL | $1.40M 100.0K sh | Dec 15, 2025 traded Dec 11, 2025 |
| 51 | Bisharat JalehDirector | Open-market sale | SELL | $140K 10.0K sh | Dec 15, 2025 traded Dec 11, 2025 |
| 50 | Lin LaurenCLO, CCO and Secretary | Open-market sale | SELL | $423K 30.2K sh | Dec 15, 2025 traded Dec 11, 2025 |
| 49 | Usen ToddDirector, Chief Executive Officer | Open-market purchase | BUY | $226K 207.3K sh | Dec 15, 2025 traded Dec 12, 2025 |
| 48 | Miller Austin ScottDirector | Open-market sale | SELL | $33K 5,051 sh | Dec 15, 2025 traded Dec 15, 2025 |
| 48 | March Stanley RaymondVP, Corporate Development | Open-market sale | SELL | $690 106 sh | Dec 15, 2025 traded Dec 15, 2025 |
| 48 | March Stanley RaymondVP, Corporate Development | Open-market sale | SELL | $1,029 158 sh | Dec 15, 2025 traded Dec 15, 2025 |
| 48 | Anderson Joshua JosephChief Technology Officer | Open-market sale | SELL | $1,074 165 sh | Dec 15, 2025 traded Dec 15, 2025 |
| 48 | Botti JeanDirector | Open-market sale | SELL | $33K 5,051 sh | Dec 15, 2025 traded Dec 15, 2025 |
| 48 | Anderson Joshua JosephChief Technology Officer | Open-market sale | SELL | $716 110 sh | Dec 15, 2025 traded Dec 15, 2025 |
| 46 | Schwartz DebraDirector | Open-market sale | SELL | $351K 4,200 sh | Dec 15, 2025 traded Dec 11, 2025 |
| 45 | GSK plc10% Owner | Open-market purchase | BUY | $27.93M 1.47M sh | Dec 15, 2025 traded Dec 11, 2025 |
| 42 | Turner Timothy WilliamDirector, Chief Executive Officer | Open-market sale | SELL | $6.95M 129.6K sh | Dec 15, 2025 traded Dec 12, 2025 |
| 40 | Anderson Joshua JosephChief Technology Officer | Open-market sale | SELL | $137 21 sh | Dec 15, 2025 traded Dec 15, 2025 |
| 40 | Bar-Zeev TomerDirector | Open-market sale | SELL | $4.37M 86.4K sh | Dec 15, 2025 traded Dec 11, 2025 |
| 40 | March Stanley RaymondVP, Corporate Development | Open-market sale | SELL | $130 20 sh | Dec 15, 2025 traded Dec 15, 2025 |
| 40 | Bar-Zeev TomerDirector | Open-market sale | SELL | $2.35M 50.0K sh | Dec 15, 2025 traded Dec 12, 2025 |
| 36 | Bar-Zeev TomerDirector | Open-market sale | SELL | $1.91M 37.2K sh | Dec 15, 2025 traded Dec 11, 2025 |
| 35 | Marley Brian TDirector | Open-market sale | SELL | $837K 15.2K sh | Dec 15, 2025 traded Dec 12, 2025 |
| 35 | Horn Daniel E.Chief Commercial Officer | Open-market sale | SELL | $591K 3,123 sh | Dec 15, 2025 traded Dec 11, 2025 |
| 35 | Kashani AliDirector, Chief Executive Officer | Open-market sale | SELL | $199K 16.7K sh | Dec 15, 2025 traded Dec 11, 2025 |
| 35 | Read BrianChief Financial Officer | Open-market sale | SELL | $88K 6,700 sh | Dec 15, 2025 traded Dec 12, 2025 |